{"id":"W3007839305","doi":"10.1200/jco.2020.38.6_suppl.439","title":"Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Cystectomy; Nivolumab; Bladder cancer; Gemcitabine; Oncology; Internal medicine; Cisplatin; Population; Clinical endpoint; Urology; Chemotherapy; Cancer; Immunotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002283643,0.0007860036,0.001505738,0.0002702577,0.000297737,0.000875794,0.0004878529,0.0010902,0.006059032],"category_scores_gemma":[0.001466436,0.0002684567,0.001753887,0.0002733654,0.0003930992,0.0009410783,0.0004469845,0.002094837,0.000676356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007963664,"about_ca_system_score_gemma":0.0009126532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007773893,"about_ca_topic_score_gemma":0.002778924,"domain_scores_codex":[0.9993305,0.0003707149,0.00003894353,0.0000976341,0.00006142069,0.0001007856],"domain_scores_gemma":[0.9994035,0.0001287014,0.0001456087,0.00003225404,0.00003690947,0.0002530342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8814768,0.008179625,0.01057684,0.001487282,0.002924648,0.0001031542,0.000171272,0.002056772,0.006582742,0.0003136809,0.008355855,0.07777124],"study_design_scores_gemma":[0.6208538,0.3027036,0.05908392,0.0002486273,0.003752379,0.0002868021,0.0001276395,0.002383527,0.001832383,0.0006741023,0.008001618,0.00005162336],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816067,0.006350119,0.0003876214,0.00169056,0.000350867,0.001508658,0.003535644,0.00008623544,0.004483553],"genre_scores_gemma":[0.9825729,0.002202627,0.0008958764,0.001837173,0.0002393224,0.001634288,0.006612352,0.00002762602,0.003977854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006059032,"threshold_uncertainty_score":0.02026945,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1345553341513558,"score_gpt":0.4258172032994331,"score_spread":0.2912618691480773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}